AR017430A1 - Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento - Google Patents

Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento

Info

Publication number
AR017430A1
AR017430A1 ARP980106365A ARP980106365A AR017430A1 AR 017430 A1 AR017430 A1 AR 017430A1 AR P980106365 A ARP980106365 A AR P980106365A AR P980106365 A ARP980106365 A AR P980106365A AR 017430 A1 AR017430 A1 AR 017430A1
Authority
AR
Argentina
Prior art keywords
amino
methyl
manufacture
preparation
maleic acid
Prior art date
Application number
ARP980106365A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR017430A1 publication Critical patent/AR017430A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980106365A 1997-12-16 1998-12-15 Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento AR017430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726568.0A GB9726568D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR017430A1 true AR017430A1 (es) 2001-09-05

Family

ID=10823694

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980106369A AR017213A1 (es) 1997-12-16 1998-12-15 Un proceso para preparar un hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona
ARP980106365A AR017430A1 (es) 1997-12-16 1998-12-15 Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980106369A AR017213A1 (es) 1997-12-16 1998-12-15 Un proceso para preparar un hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona

Country Status (37)

Country Link
US (2) US7045633B2 (2)
EP (1) EP1045847A1 (2)
JP (1) JP2002508372A (2)
KR (1) KR100549143B1 (2)
CN (3) CN101412714A (2)
AP (1) AP1441A (2)
AR (2) AR017213A1 (2)
AU (1) AU2272399A (2)
BG (1) BG64905B1 (2)
BR (1) BR9813604A (2)
CA (1) CA2314965A1 (2)
CO (1) CO4990927A1 (2)
CZ (1) CZ299970B6 (2)
DZ (1) DZ2680A1 (2)
EA (1) EA002355B1 (2)
EG (2) EG23694A (2)
GB (1) GB9726568D0 (2)
HR (1) HRP20000405A2 (2)
HU (1) HUP0100500A3 (2)
ID (1) ID24744A (2)
IL (1) IL136381A (2)
IN (1) IN190821B (2)
MA (1) MA26582A1 (2)
MY (1) MY135770A (2)
NO (1) NO317253B1 (2)
NZ (1) NZ504704A (2)
OA (1) OA11634A (2)
PE (1) PE20000057A1 (2)
PL (1) PL341147A1 (2)
RS (1) RS50079B (2)
SK (1) SK286197B6 (2)
TR (2) TR200001798T2 (2)
TW (1) TW467913B (2)
UA (1) UA63980C2 (2)
UY (2) UY25310A1 (2)
WO (1) WO1999031094A1 (2)
ZA (1) ZA9811505B (2)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
AU765498B2 (en) * 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
HK1045152A1 (zh) * 1999-04-23 2002-11-15 Smithkline Beecham Plc 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
EP0656900A4 (en) 1992-08-28 1995-09-06 Merck & Co Inc CATIONIC 2-HETEROARYLPHENYL-CARBAPENEM DERIVATIVES AS AN ANTIBACTERIAL AGENT.
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW245716B (2) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US6664278B2 (en) * 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
CZ432299A3 (cs) * 1998-06-02 2000-08-16 Smithkline Beecham Plc Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion
AU765498B2 (en) 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
HK1045152A1 (zh) 1999-04-23 2002-11-15 Smithkline Beecham Plc 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
PL351684A1 (en) 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt

Also Published As

Publication number Publication date
EA200000655A1 (ru) 2000-12-25
EA002355B1 (ru) 2002-04-25
AU2272399A (en) 1999-07-05
CZ20002205A3 (cs) 2000-11-15
CZ299970B6 (cs) 2009-01-07
TW467913B (en) 2001-12-11
AP2000001830A0 (en) 2000-06-30
PL341147A1 (en) 2001-03-26
AR017213A1 (es) 2001-08-22
RS50079B (sr) 2009-01-22
KR100549143B1 (ko) 2006-02-03
PE20000057A1 (es) 2000-03-09
UA63980C2 (en) 2004-02-16
TR199802626A3 (tr) 1999-10-21
CA2314965A1 (en) 1999-06-24
MA26582A1 (fr) 2004-12-20
SK9102000A3 (en) 2001-01-18
BR9813604A (pt) 2000-10-10
NZ504704A (en) 2003-03-28
IL136381A0 (en) 2001-06-14
EG23694A (en) 2007-05-15
NO317253B1 (no) 2004-09-27
JP2002508372A (ja) 2002-03-19
IN190821B (2) 2003-08-23
HRP20000405A2 (en) 2000-12-31
HUP0100500A2 (hu) 2002-05-29
TR200001798T2 (tr) 2000-11-21
BG104595A (en) 2001-02-28
UY25305A1 (es) 2000-12-29
IL136381A (en) 2003-09-17
BG64905B1 (bg) 2006-08-31
EP1045847A1 (en) 2000-10-25
WO1999031094A1 (en) 1999-06-24
YU36200A (sh) 2003-12-31
NO20003068D0 (no) 2000-06-15
ID24744A (id) 2000-08-03
TR199802626A2 (xx) 1999-10-21
KR20010033142A (ko) 2001-04-25
CN1281454A (zh) 2001-01-24
CN101412713A (zh) 2009-04-22
US20060189659A1 (en) 2006-08-24
MY135770A (en) 2008-06-30
UY25310A1 (es) 1999-07-19
AP1441A (en) 2005-07-30
NO20003068L (no) 2000-06-15
SK286197B6 (sk) 2008-05-06
HUP0100500A3 (en) 2002-08-28
OA11634A (en) 2004-11-22
GB9726568D0 (en) 1998-02-11
CN101412714A (zh) 2009-04-22
US7045633B2 (en) 2006-05-16
ZA9811505B (en) 2000-11-06
CO4990927A1 (es) 2000-12-26
US20040097553A1 (en) 2004-05-20
DZ2680A1 (fr) 2005-02-20
EG21417A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
AR023564A1 (es) Una forma polimorfica de sal del acido maleico derivado del tiazolidina-2,4 diona, una composicion farmaceutica y el uso del mismo para la fabricacion deun medicamento
IL78831A (en) 6-(thiazolidin-2,4-dion-5-ylmethyl)chromans and structurally related compounds as hypoglycemic agents
AR031069A1 (es) Cristal de un compuesto benzimidazol, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima
UY25305A1 (es) Hidrato de la sal del ácido maleico de la 5-[4-[2-(n-metil-n-2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
AR017214A1 (es) Un proceso para preparar un hidrato de la sal del acido maleico de 5-[4[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona
AR023561A1 (es) Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
EA200000656A1 (ru) Замещенное производное тиазолидиндиона, способ его получения и его фармацевтическое применение
AP1607A (en) Thiazolidinedione derivative and its use as antidiabetic.
AR015894A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos
NZ513922A (en) Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
EA200101101A1 (ru) Новый фармацевтический препарат
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
HUP9900320A3 (en) Optically active thiazolidinone derivatives, preparation thereof, pharmageutical compositions containing these compounds as active ingredients and use of thia-or oxazolidine derivatives for preparation of pharmaceutical compositions
ECSP982779A (es) Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina
AR017867A1 (es) Un hidrato de la sal del acido maleico de 5-4-2-(n-metil-n(2-piridil)amino)etoxi bencil tiazolidin-2,4-diona, un proceso para su preparacion, una composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento.
AU2001284285A1 (en) A thiazolidinedione derivative and its use as antidiabetic
ECSP982780A (es) Nuevo producto farmaceutico proceso para su preparacion y su uso en medicina
ECSP003434A (es) Nuevos compuestos
NZ518545A (en) Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical
TH84544A (th) ไฮเดรทชนิดใหม่
TH51743A (th) สารผสมป้องกันโรคเบาหวานชนิดใหม่
TH58463A (th) สารประกอบต่อต้านเบาหวานชนิดใหม่

Legal Events

Date Code Title Description
FC Refusal